Greg Vosganian

Greg Vosganian, MD, currently serves as Vice President of Clinical Development at Adicet Bio, Inc., overseeing the life cycle strategy for innovative CAR-T programs. Prior to this role, Greg held a similar position at Kartos Therapeutics, Inc./Telios Pharma, where responsibilities included the development of clinical strategies for hematologic treatments. Greg’s extensive experience encompasses positions as Senior Medical Director at BeiGene, Medical Director at AbbVie, and Medical Director at Gilead Sciences, focusing on oncology and hematology clinical development. Early career roles included serving as Assistant Medical Director at Genentech and as a staff physician and fellow in hematology/oncology at Scripps Health. Greg completed medical training at the Medical College of Virginia and holds a Bachelor of Science degree in Biological Sciences from Stanford University.